Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Bulgaria Dynamic System For Purchases Of Laboratory Consumables And Reagents 2029-04-02
Bulgaria Dynamic System For Purchasing Laboratory Supplies And Reagents 2029-04-02
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Ganirelix, Atc H01cc01 For The Period June 1st, 2026 - May 31st, 2028 (plus Extension Option 1x12 Months) 2029-04-05
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Fondaparinux, Atc B01ax05 For The Period June 1st, 2026 - May 31st, 2028 (plus Extension Option 1x12 Months) 2029-04-05
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Abs. 8 Sgb V For The Active Ingredient Methylprednisolone, Atc D07ac14 For The Period 01.06.2026 - 31.05.2028 (plus Extension Option 1x12 Months) Methylprednisolone 2029-04-05
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Abs. 8 Sgb V For The Active Ingredient Mesalazine, Valid From 01.06.26 To 31.05.28 (plus Option For 1x12 Months). Mesalazine 2029-04-05
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Prednicarbate, Atc D07ac18 For The Period June 1st, 2026 - May 31st, 2028 (plus Extension Option 1x12 Months) 2029-04-05
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Abs. 8 Sgb V For The Active Ingredient Mesalazine, Excluding Dafo Tmr, For The Period From 01.06.2026 To 31.05.2028 (plus An Optional Extension Of 12 Months). Mesalazine 2029-04-05
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Abs. 8 Sgb V For The Active Ingredient Dalbavancin For The Period From 01.06.2026 To 31.05.2028 (plus An Extension Option Of 1x12 Months). Dalbavancin 2029-04-05
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Bexarotene, Atc L01xf03 For The Period June 1st, 2026 - May 31st, 2028 (plus Extension Option 1x12 Months) 2029-04-05
Whats app